INTRODUCTION: Alterations of serum lipid profiles have been reported widely among Human Immuno deficiency Virus (HIV) positive patients on Highly Active Anti Retroviral Therapy (HAART). However, there are few data on serum lipid profile among treatment naïve HIV positive patients in our environment. OBJECTIVES: To describe the pattern of lipid profile among treatment naïve HIV positive patients and changes following HAART initiation. METHODS: One hundred and thirty HIV positive patients seen in HIV center in an urban area in Nigeria and 44 matched individuals were recruited. Data were collected on socio demographic characters, baseline lipid profiles and CD4 count. Values of lipid parameters were retrieved after 12 months on HAART. RESULTS: The mean Low density lipoprotein(LDL) was 2.26+ 0.9 mmol/l among the test group compared with 0.96+0.39 mmol/L among the control, p value=0.000. The mean High density lipoprotein (HDL) was also significantly lower, 0.8+0.6 mmol/L reaching a dyslipidemic level, in the HIV positive group than the control, p value = 0.00. Tuberculosis/HIV co infected patients had a significantly elevated mean LDL, p=0.002. CONCLUSION: Abnormality of serum lipid is common among treatment naïve HIV patients seen in Nigeria. The NNRTI regimen is associated with elevation of HDL and some stabilization of TC and TG.
INTRODUCTION: Alterations of serum lipid profiles have been reported widely among Human Immuno deficiency Virus (HIV) positivepatients on Highly Active Anti Retroviral Therapy (HAART). However, there are few data on serum lipid profile among treatment naïve HIV positive patients in our environment. OBJECTIVES: To describe the pattern of lipid profile among treatment naïve HIV positive patients and changes following HAART initiation. METHODS: One hundred and thirty HIV positive patients seen in HIV center in an urban area in Nigeria and 44 matched individuals were recruited. Data were collected on socio demographic characters, baseline lipid profiles and CD4 count. Values of lipid parameters were retrieved after 12 months on HAART. RESULTS: The mean Low density lipoprotein(LDL) was 2.26+ 0.9 mmol/l among the test group compared with 0.96+0.39 mmol/L among the control, p value=0.000. The mean High density lipoprotein (HDL) was also significantly lower, 0.8+0.6 mmol/L reaching a dyslipidemic level, in the HIV positive group than the control, p value = 0.00. Tuberculosis/HIV co infectedpatients had a significantly elevated mean LDL, p=0.002. CONCLUSION: Abnormality of serum lipid is common among treatment naïve HIVpatients seen in Nigeria. The NNRTI regimen is associated with elevation of HDL and some stabilization of TC and TG.
Authors: D Périard; A Telenti; P Sudre; J J Cheseaux; P Halfon; M J Reymond; S M Marcovina; M P Glauser; P Nicod; R Darioli; V Mooser Journal: Circulation Date: 1999-08-17 Impact factor: 29.690
Authors: Bela F Asztalos; Ernst J Schaefer; Katalin V Horvath; Caitlin E Cox; Sally Skinner; Jul Gerrior; Sherwood L Gorbach; Christine Wanke Journal: Atherosclerosis Date: 2005-06-01 Impact factor: 5.162
Authors: J Constans; J L Pellegrin; E Peuchant; M F Dumon; I Pellegrin; C Sergeant; M Simonoff; G Brossard; P Barbeau; H Fleury Journal: Eur J Clin Invest Date: 1994-06 Impact factor: 4.686
Authors: Gerald S Bloomfield; Prateeti Khazanie; Alison Morris; Cristina Rabadán-Diehl; Laura A Benjamin; David Murdoch; Virginia S Radcliff; Eric J Velazquez; Charles Hicks Journal: J Acquir Immune Defic Syndr Date: 2014-09-01 Impact factor: 3.731
Authors: David G Dillon; Deepti Gurdasani; Johanna Riha; Kenneth Ekoru; Gershim Asiki; Billy N Mayanja; Naomi S Levitt; Nigel J Crowther; Moffat Nyirenda; Marina Njelekela; Kaushik Ramaiya; Ousman Nyan; Olanisun O Adewole; Kathryn Anastos; Livio Azzoni; W Henry Boom; Caterina Compostella; Joel A Dave; Halima Dawood; Christian Erikstrup; Carla M Fourie; Henrik Friis; Annamarie Kruger; John A Idoko; Chris T Longenecker; Suzanne Mbondi; Japheth E Mukaya; Eugene Mutimura; Chiratidzo E Ndhlovu; George Praygod; Eric W Pefura Yone; Mar Pujades-Rodriguez; Nyagosya Range; Mahmoud U Sani; Aletta E Schutte; Karen Sliwa; Phyllis C Tien; Este H Vorster; Corinna Walsh; Rutendo Zinyama; Fredirick Mashili; Eugene Sobngwi; Clement Adebamowo; Anatoli Kamali; Janet Seeley; Elizabeth H Young; Liam Smeeth; Ayesha A Motala; Pontiano Kaleebu; Manjinder S Sandhu Journal: Int J Epidemiol Date: 2013-12 Impact factor: 7.196
Authors: Zvenyika Ar Gomo; James G Hakim; Sarah A Walker; Willard Tinago; Gibson Mandozana; Cissy Kityo; Paula Munderi; Elly Katabira; Andrew Reid; Diana M Gibb; Charles F Gilks Journal: AIDS Res Ther Date: 2014-10-02 Impact factor: 2.250
Authors: Jasmine G Lyons; Karen Sliwa; Melinda J Carrington; Frederick Raal; Sandra Pretorius; Friedrich Thienemann; Simon Stewart Journal: BMJ Open Date: 2014-07-14 Impact factor: 2.692
Authors: Cajetan C Onyedum; Ekenechukwu E Young; Michael O Iroezindu; Chinwe J Chukwuka; Uchenna I Nwagha Journal: Indian J Endocrinol Metab Date: 2014-09